The bidding window for the Sugs Lloyd SME IPO was open from August 29, 2025, to September 2, 2025. The basis of allotment will be finalised today, September 3, 2025. Here’s how you can check the IPO allotment status.
Sugs Lloyd IPO is a book-building issue of ₹85.66 crores, consisting entirely of a fresh issue of 0.70 crore shares. The price band is set at ₹117 to ₹123 per share. The tentative listing on BSE SME is September 5, 2025.
3Dimension Capital Services Ltd. is the book-running lead manager, and Kfin Technologies is the registrar for the issue.
The net proceeds from the fresh issue will be used to:
(September 2, 2025, end of the day)
Category |
Subscription (times) |
Qualified Institutional Investors (QIBs) |
2.03 |
Non-Institutional Investors (NIIs) |
4.70 |
Individual Investors (IND category bidding for 2 Lots) |
2.12 |
Total |
3.11 |
As of September 3, 2025, the Sugs Lloyd IPO GMP stood at ₹0. The estimated listing price is ₹123, at par with the upper price brand.
Source: InvestorGain Report dated 3 September 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Sugs Lloyd is an engineering and infrastructure solutions company operating primarily in the renewable energy sector, with strong competencies in solar power, electrical transmission and distribution, and civil EPC (Engineering, Procurement, and Construction) projects.
Their core services include end-to-end execution of solar energy projects, development of transmission and distribution networks, construction of power substations, and the refurbishment and upgrading of existing electrical infrastructure.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here